Skip to main content
OpenTrials
Completed

NCT Number: NCT03811626

Efficacy of Multidimensional Management of Mild Traumatic Brain Injury

Unfavorable outcomes (UO) are seen in 15 to 20% of patients with mild traumatic brain injury (mTBI). Early identification of patients at risk for UO is crucial for suitable management to be initiated, increasing their chances for a return to a normal life. The investigators previously developed a diagnostic tool enabling early identification (8 to 21 days after the injury) of patients likely to develop UO. In the present study, the investigators examined the value and beneficial effects of early multidimensional management (MM) on prognosis. The investigators used a diagnostic tool to classify 221 mTBI patients as UO (97) or FO (favorable outcome) (124). Patients whose initial risk factors point to UO are at risk of developing post-concussion syndrome (PCS). UO patients were randomized into 2 groups: a group that underwent MM (cognitive-behavioral rehabilitation) (34) and a group with no specific management (46). At 6 months, these 2 groups were compared and the impact of MM on outcome was assessed. Among patients initially classified as FO (101), 95% had FO at 6 months and only 5 had PCS as defined by DSM-IV classification. Of the UO patients who received MM, 94% had no PCS 6 months after injury, whereas 52% of the UO patients who did not receive MM had persistent PCS. The effect of MM on the recovery of patients at 6 months, once adjusted for the main confounding factors, was statistically significant (p<0.001). These results show that the initiation of MM after early identification of at-risk mTBI patients can considerably improves their prognosis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chu Bicetre, Le Kremlin-Bicêtre, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 to 65 who have suffered mTBI, have health care coverage, who understand French, who can be followed for 6 months, and who are able to understand, reply, and cooperate.

Exclusion criteria

  • Patient intubated and/or ventilated and/or sedated upon arrival at hospital
  • Patient with injury to the medulla and with neurological signs or multiple injuries (at least 1 of which is life-threatening)
  • Brain injury incurred during a suicide attempt
  • Patient presenting psychiatric or psychological disorders that are debilitating and/or interfere with follow-up and/or evaluation
  • Psychoactive treatment ongoing at the time of injury
  • History of hospitalization in specialized a psychiatric setting and/or sick leave for psychological reasons
  • Patient with a neurological disorder
  • Patient with substance dependence
  • Subject under guardianship or wardship

Treatment and study plan

cognitive-behavioral rehabilitation

Procedure

Combination of clinical examination and neuropsychological and psychological tests

Primary outcomes

  1. Change in quality of life

    Time frame: Baseline, 6 months -

    Change in quality of life assessed by QOLIBRI (Quality of Life after Brain Injury) Scale - QOLIBRI scale assess health-related quality of life (HRQoL) of individuals after traumatic brain injury. QOLIBRI is a comprehensive questionnaire with 37 items covering six dimensions of HRQoL after TBI. The QOLIBRI scores are reported on a 0-100 scale , where 0=worst possible quality of life and 100=best possible quality of life.

Sponsors and collaborators

Lead sponsor

Institut de Recherche sur la Moelle épinière et l'Encéphale

Other

Registry information

Official study title

Efficacy of Multidimensional Management of Mild Traumatic Brain Injury : A Randomised Clinical Trial

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Jan 22, 2019
Registry last updated
Jan 24, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.